G1 Therapeutics, Inc.. (2/21/18). "Press Release: G1 Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Recent Operational Highlights". Research Triangle Park, NC.

	Organisation	G1 Therapeutics Inc. (Nasdaq: GTHX)
	Organisation 2	AstraZeneca plc (LSE: AZN)
	Group	AstraZeneca (Group)
	Product	trilaciclib
	Product 2	G1T48 (G1 Therapeutics)

Original document
accessed by [iito] on 2018-03-09

Record changed: 2023-06-05

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

More documents for G1 Therapeutics Inc. (Nasdaq: GTHX)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)